Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073983
Status:
COMPLETED
Last Update Posted:
2012-03-12
First Post:
2003-12-10
Brief Title:
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma Closed to Accrual as of 122106 or Ewings Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
Sponsor:
Sarcoma Alliance for Research through Collaboration
Organization:
Sarcoma Alliance for Research through Collaboration
Organization Data
Organization:
Sarcoma Alliance for Research through Collaboration
Class:
OTHER
Study ID:
SARC003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sarcoma Alliance for Research through Collaboration
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Shreyaskumar Patel MD
Old Organization:
SARC